Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma.

M M Chokshi1, J A Marrero

  • 1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century - authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.

Alimentary pharmacology & therapeutics·2016
Same author

First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study.

International journal of clinical practice·2012
Same author

The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.

Alimentary pharmacology & therapeutics·2009
Same author

Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

Alimentary pharmacology & therapeutics·2009
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Hepatocellular carcinoma incidence is rising, with smoking identified as a key risk factor. Treatment options like liver transplantation and resection show varying long-term benefits based on patient factors.

Area of Science:

  • Hepatology
  • Oncology
  • Cancer Research

Background:

  • Increasing publication trends in hepatocellular carcinoma research noted between 1999-2001.
  • Confirmed rise in hepatocellular carcinoma incidence within the United States.
  • Established tobacco smoking as a significant risk factor for hepatocellular carcinoma development.

Purpose of the Study:

  • To summarize recent advancements in hepatocellular carcinoma research.
  • To highlight key findings on risk factors, angiogenesis, and treatment modalities.
  • To compare surgical interventions for hepatocellular carcinoma.

Main Methods:

  • Literature review and analysis of studies published between 1999-2001.
  • Identification and synthesis of research on hepatocellular carcinoma risk factors.

Related Experiment Videos

  • Comparative analysis of resection versus liver transplantation outcomes.

    • Main Results:

    • Tobacco smoking confirmed as a risk factor for hepatocellular carcinoma.
    • Angiogenesis identified as critical for tumor development; inhibition shows therapeutic potential.
    • Liver transplantation demonstrated superior long-term outcomes compared to resection.
    • Resection identified as optimal for specific patient groups (no portal hypertension, preserved liver function).

    Conclusions:

    • Hepatocellular carcinoma incidence and research are increasing.
    • Smoking cessation and anti-angiogenic therapies are crucial for management.
    • Treatment decisions for hepatocellular carcinoma require individualized patient assessment.